Colorectal Cancer
The role of biomarker testing in cancer
Biomarkers can play important roles in cancer treatment, but what are they and what can they tell doctors?
The term “biomarker” may be unfamiliar to people until they or someone they love has been diagnosed with cancer. In general terms, a biomarker is a trait that can be measured (or is expressed) in tissue, blood, or body fluids. Relative to cancer, biomarker testing, which may also be referred to as genetic testing, involves obtaining a sample of tumor material to identify genes, proteins or other molecules that can provide information about unique disease characteristics. Biomarkers are often discussed using acronyms.
Obtaining biomarker information can help oncologists determine the treatment options which may most effective based on the unique make-up of a tumor. Today this analysis is regularly offered to patients with solid tumors including colorectal cancer. Having knowledge around genetic mutations or molecular changes can often mean a targeted therapy may make sense as a treatment option. So having this data enables personalized treatment planning, a relatively new innovation. And many targeted options are associated with fewer side effects.
Biomarker information can also aid oncologists in understanding the likely course of cancer including how aggressive it may become. This can help with patient conversations around prognosis which may be important to deciding which treatment or protocol to pursue.
There are several common biomarkers relevant to colorectal cancer. The most studied include:
- KRAS: Mutations in the KRAS gene can influence treatment decisions and the use of certain targeted therapies. There are many clinical studies looking at therapies relative to a KRAS mutation. Testing for this is commonly offered to patients diagnosed with metastatic cancer.
- NRAS: These mutations have a very similar effect on colorectal cancer cells as KRAS mutations, but are less common.
- BRAF: Mutations in the BRAF gene may be associated with a more aggressive cancer for which targeted therapy may be recommended.
- MSI-H/dMMR: Microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) status is a key biomarker for identifying patients who may benefit from immunotherapy.
- PD-L1: Programmed death-ligand 1 (PD-L1) expression can also help identify those patients who might benefit from immunotherapy.
- EGFR: Epidermal growth factor receptor (EGFR) expression can be targeted by certain monoclonal antibodies. This is an area of high interest to clinical researchers for new treatments.
- CEA: Carcinoembryonic antigen (CEA) is one of the first biomarkers studied and associated with colorectal cancer. It can be used to monitor treatment response and detect recurrence.
If you or a loved one has been diagnosed with colorectal cancer and have not yet been offered biomarker testing, it may be a good idea to ask if it is appropriate based on the specifics of the case. Today most larger cancer centers offer such testing and it is increasingly covered by insurance plans given how results can be used to guide treatment decisions.
Once a sample is obtained, it may take several days or weeks to get the results. Be sure to ask your provider what the expected timeline is and how results will be communicated. Sometimes this discussion will be had at a scheduled visit though the result may appear in a patient portal application ahead of an appointment. In this case, the result may be hard to understand if it is a lab report written in clinical language. In the meantime you can write down questions about what the results mean, like:
- Is there any change to my treatment plan?
- Are there targeted therapies available?
- Does the result affect my prognosis?
- Are there any clinical trials available?
Biomarkers are a relatively new and important tool in cancer treatment planning. Understanding specific characteristics of a tumor allows healthcare providers and patients to have more informed treatment discussions. If you need further clarification about biomarker testing or results, reach out to your care team.
References:
Biomarker Testing for Cancer Treatment | NCI
KRAS mutation in colon cancer: What does it mean? | Medica News Today
Colorectal Cancer Biomarkers [2023 Patient Guide] | Fight CRC
Published Date October 16, 2024
Latest News
Leukemia (AML)
A simple guide to understanding chemo
Chemo is an effective cancer treatment - but what is it exactly and why does it work?
2024-12-09T14:25:00Z
Eczema
Self-care tips during eczema flare-ups
Eczema can be emotionally draining and physically uncomfortable - learn how self-care can change your outlook
2024-11-26T18:46:00Z
Healthy Volunteers
What is a Phase 1 trial?
Phase 1 trials are necessary first steps on the road to clinical breakthroughs and healthy volunteers can help make these a reality.
2024-11-11T15:35:00Z
Colorectal Cancer
The role of biomarker testing in cancer
Biomarkers can play important roles in cancer treatment, but what are they and what can they tell doctors?
2024-10-16T18:18:00Z
Hypertension
Home-based exercise tips for blood pressure control
Getting heart-healthy physical activity doesn't have to mean running a marathon or joining an expensive gym.
2024-09-08T18:30:00Z
Leukemia (AML)
What helps with nausea besides medicine?
Nausea is an unfortunate aspect of cancer treatment - what may help reduce this side effect?
2024-08-31T18:30:00Z
Healthy Volunteers
Common misconceptions about clinical research
Many people have never participated in a clinical trial so it can be hard to separate fact from myth - here are some of the most common myths debunked.
2024-08-28T21:23:00Z
Obesity
The basics of BMI
BMI, or Body Mass Index, is a standard way to assess weight status - learn why and where it came from
2024-08-22T13:50:00Z
Colorectal Cancer
Why is Colorectal Cancer striking at younger ages?
The number of people being diagnosed with colorectal cancer under the age of 50 has greatly increased - what might be the cause of this troubling trend?
2024-08-14T16:12:00Z
Hypertension
Four foods linked with lower blood pressure
While the foods you eat can raise the risk of developing hypertension, there are also options that can help lower blood pressure.
2024-08-01T18:30:00Z
Obesity
A primer on GLP-1 receptor agonists for weight loss
An overview on select GLP-1 receptor agonist treatments that help promote blood sugar management and weight loss
2024-07-31T18:30:00Z
Multiple Myeloma
Life with a rare disease
Experiencing serious health challenges is difficult enough - having a relatively unknown condition adds additional complexity
2024-07-08T22:02:00Z
Eczema
Atopic Dermatitis: signs and stages
Understanding how atopic dermatitis looks, feels and changes during a flare-up is helpful to patients seeking greater control of their condition
2024-07-01T16:12:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Speaking with your PCP about MASH
Engaging your primary doctor in a conversation about risk for MASH liver disease doesn't have to be scary
2024-06-25T12:15:00Z
Alzheimer's Disease
New Alzheimer’s Disease research breakthroughs
The 2020s have been the most impactful decade so far for the debilitating form of dementia
2024-05-02T18:30:00Z
Breast Cancer
Talking to family about cancer genes
Though this conversation may be difficult, it might be vitally important for your loved ones
2024-02-05T18:30:00Z
Lupus
Lupus (Systemic Lupus Erythematosus) and Diet
Can what you eat make a difference?
2024-04-15T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Learning you need a liver biopsy: staying calm
Approaches to stay in control before, during and after a biopsy
2023-12-27T18:30:00Z
Diabetes
The recent rise of walking as exercise
Grab your sneakers, grab a friend, or grab your dog and get moving!
2023-12-05T18:30:00Z
Renal Cell Carcinoma
Coping with the holidays during cancer treatment
Getting ready to face a new year while facing cancer is no easy task
2023-11-23T18:30:00Z
Multiple Sclerosis (MS)
Possible link between multiple sclerosis and viral infection?
Researchers are looking to learn more about if and how a virus can trigger multiple sclerosis
2023-10-25T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Losing excess weight together with an active lifestyle helps with the management of MASH, but where to begin?
2023-09-05T18:30:00Z
Lung Cancer
Talking to loved ones about your clinical trial
How to talk to family and friends when you are thinking of changing cancer treatment plans for a research option
2023-08-14T18:30:00Z
Lung Cancer
Learning you have lung cancer as a non-smoker
Lung cancer can be a shocking diagnosis when you've never smoked - how can it be?
2023-08-15T18:30:00Z
Prostate Cancer
Does a high PSA score always mean cancer?
Learn more about this common test for older men and how it relates to cancer risk
2023-07-10T18:30:00Z
Breast Cancer
Understanding the differences between mastectomy and lumpectomy
Two different surgical options both seeking the same outcome
2023-07-07T18:30:00Z
Lupus
New treatments are on the horizon for lupus patients
From biologics to CAR-T, developments in clinical research for SLE have opened new treatment doors for patients.
2023-05-22T16:15:00Z
Multiple Myeloma
Understanding eligibility criteria for clinical research studies
Clinical trials utilize sets of criteria to determine if a person is a good fit - but what are these and what do they mean?
2023-04-05T18:30:00Z
Renal Cell Carcinoma
Learning you need a biopsy: staying calm
Approaches to stay in control before, during and after a diagnostic biopsy
2023-03-14T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Pharmaceutical companies are rushing to fill the NASH treatment gap
2023-03-14T18:30:00Z